Related Experiment Video
Updated: Aug 12, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Myocardial infarction: signs symptoms and treatment
1School of Nursing and Midwifery, University of East Anglia.
Insights
Myocardial infarction (MI) is a leading cause of death in the UK, affecting 300,000 annually. Rapid diagnosis and thrombolytic therapy, aiming for a 20-minute "door-to-needle" time, are crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Myocardial infarction (MI) is a significant cause of mortality and morbidity in the UK.
- Around 300,000 individuals experience an MI yearly, with approximately 140,000 fatalities.
Purpose of the Study:
- To provide an overview of the signs, symptoms, and diagnosis of acute myocardial infarction.
- To present contemporary management strategies recommended by the National Service Framework (NSF).
- To briefly explore nursing interventions for MI patients.
Main Methods:
- Review of current guidelines and recommendations for MI management.
- Overview of diagnostic approaches for acute chest pain.
- Discussion of treatment protocols, including thrombolytic therapy.
Main Results:
- Emphasizes the critical need for rapid patient management.
- Highlights the target "door-to-needle" time of 20 minutes for thrombolytic therapy.
- Outlines key signs, symptoms, and diagnostic criteria for MI.
Conclusions:
- Prompt recognition and management of MI are essential to reduce death and disability.
- Adherence to NSF recommendations, including reduced "door-to-needle" times, is vital.
- Effective nursing interventions play a role in optimizing patient care during and after MI.
Abstract:
From early middle age onwards myocardial infarction is recognised as being a major cause of death and disability in this country. Approximately 300,000 people in the UK experience an MI each year and about 140,000 will die as a result. The rapid management of patients with chest pain should ensure that there is no more than 30 minutes delay in decision-making and initiation of thrombolytic therapy. This 'door-to-needle' time should be reduced to 20 minutes from April 2003 in line with national service framework recommendations. This article provides an overview of the signs, symptoms and diagnosis of this acute condition. The contemporary management/treatment advocated in the NSF is presented and nursing interventions are explored briefly.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Introduction Cardiac Emergencies

